|
|
By mobstr, on January 23rd, 2012
Highlights from recent Life Science venture capital news.
First Venture Round
18.01.2012 – Cambridge, MA
RaNA Therapeutics Closes $20.7M Series A Financing
RaNA Therapeutics, a Cambridge, Mass.-based company that is developing drugs by modulating disease-associated long non-coding RNA (lncRNA) and restoring normal expression of individual targeted genes, has completed a $20.7m Series A financing. The round was co-led by Atlas Venture, SR One, and Monsanto, with participation of Partners Innovation Fund. http://www.finsmes.com/2012/01/rana-therapeutics-closes-20-7m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29&utm_content=Google+Reader
Secondary Venture Round
17.01.2012 – Atlanta, GA
Sharecare Announces $14 Million Growth Equity Financing Led by Galen Partners
Sharecare, an interactive health and wellness social platform providing people with access to expert-developed answers, information and programs to live their healthiest life, today announced that it has secured $14 million growth equity financing led by Galen Partners along with TomorrowVentures, LLC. The proceeds of the financing will enable Sharecare to accelerate the development of innovative programs, services and tools that foster healthier living and unite people across the healthcare continuum to deliver and receive optimal care. http://www.sharecare.com/static/sharecare-announces-14-million-dollar-growth-equity-financing
18.01.2012 – Alpharetta, GA
Carticept Medical Closes $10M Series C Financing Round
Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has has completed a $10 million round of financing, led by existing investors Domain Associates, New Enterprise Associates and SonoSite, Inc. The financing will provide funding for the commercial launch of the Company’s Navigator™ Delivery System (DS), a computer?controlled drug delivery system that redefines medication delivery by integrating ultrasound guidance to increase the efficiency, accuracy and safety of administering medications for joint pain. http://www.carticept.com/press-release-011812.html
17.01.2012 – Brentwood, TN
Change Healthcare Closes Series C with Support from BlueCross BlueShield Venture Partners and Sandbox Industries
Healthcare cost transparency company Change Healthcare Corporation today announced the second closing of its Series C round of funding with investment from BlueCross BlueShield Venture Partners (BCBSVP) and Sandbox Industries. Mitsui & Co. Global Investment, Inc. (MGI) along with the West Health Investment Fund, LLC, and existing investor, Solidus Co., invested in an initial Series C closing in September 2011. In total, the Series C investment of $9.3 million exceeds the Company’s initial fundraising goals. http://www.changehealthcare.com/downloads/releases/2012.01.17%20Change%20Healthcare%20Series%20C%20Funding.pdf
This Week In Venture Capital is brought to you by VM Index from Venture Market Intelligence – Venture Capital made easier
VM Index is an online Life Science, Med Tech & Biotech venture capital funding tool with expert data that enables companies to raise more money, faster and at a better valuation than they could otherwise.
By mobstr, on January 23rd, 2012
Highlights from recent Life Science venture capital news.
First Venture Round
18.01.2012 – Cambridge, MA
RaNA Therapeutics Closes $20.7M Series A Financing
RaNA Therapeutics, a Cambridge, Mass.-based company that is developing drugs by modulating disease-associated long non-coding RNA (lncRNA) and restoring normal expression of individual targeted genes, has completed a $20.7m Series A financing. The round was co-led by . . . → Read More: Life Science Venture Capital Investment News Round Up – 23 January 2012
By mobstr, on January 19th, 2012
A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week.
Overall Weekly Totals
Total No. Deals
NA
EU
Total Raised $
Total Raised €
70
55
15
686.5
538.2
North America
No. Deals
Total $
Total €
Average $
Average €
55
546.3
428.7
11.9
9.3
Europe
No. Deals
Total $
Total €
Average $
Average €
15
140.2
109.5
11.7
9.1
Breakdown By Sector
Life Sciences
No. Deals
NA
EU
Total $
Total €
25
7
18
349.9
273.8
Average Deal NA & EU
$
€
17.5
13.7
Largest Deals
Company Name
Region
Stage
$m
€m
Warp Drive . . . → Read More: Venture Capital Investment – 19 January 2011
By mobstr, on January 18th, 2012
Highlights from the past week’s VC Investment Company news
Flagship Ventures Closes $270M Earl Stage Venture Capital Fund
Flagship Ventures, a leading venture capital firm focused on healthcare and sustainability, today announced the year-end 2011 close of its largest fund to date, raising $270 million for Flagship Ventures Fund IV L.P., exceeding its target of $250 million. Investors . . . → Read More: VCs & Venture Capital Investment Company News – 18 January 2012
By mobstr, on January 17th, 2012
Highlights from recent IT venture capital investment activity
North America
Secondary Venture Round
11.01.2012 – Hazlet, NJ
iCIMS – Leading SaaS Provider, Secures $35 Million
HR talent software vendor iCIMS has a new business partner and $35 million to spend on expansion. The company announced this morning that private equity fund Susquehanna Growth Equity has taken a minority stake . . . → Read More: IT Venture Capital Investment News Round Up – 17 January 2012
By mobstr, on January 16th, 2012
Highlights from recent Life Science venture capital news.
North America
Secondary Venture Round
10.01.2012 – Cambridge, MA
Warp Drive Bio Launches With $125M from Third Rock, Greylock, Sanofi
Warp Drive is being launched with $125 million in funding from Third Rock and French pharmaceutical giant Sanofi (NYSE: SNY). Greylock Partners also participated in the financing. Warp Drive was co-founded by Greg . . . → Read More: Life Science Venture Capital Investment News Round Up – 16 January 2012
By mobstr, on January 12th, 2012
A round up of deal activity in IT, Life Science, Med Tech & Biotech Venture Capital Investment over the past week.
Overall Weekly Totals
Total No. Deals
NA
EU
Total Raised $
Total Raised €
62
52
10
448.5
347.8
North America
No. Deals
Total $
Total €
Average $
Average €
52
429.0
330.6
9.8
7.5
Europe
No. Deals
Total $
Total €
Average $
Average €
10
19.5
17.2
3.9
3.4
Breakdown By Sector
Life Sciences
No. Deals
NA
EU
Total $
Total €
14
10
4
134.5
105.9
Average Deal NA & EU
$
€
13.5
10.6
Largest Deals
Company Name
Region
Stage
$m
€m
CytoPherx
NA
SVR
34.0
26.1
Midatech
EU
FVR
9.8
7.6
TMT
No. Deals
NA
EU
Total $
Total €
48
42
6
314.0
241.9
Average . . . → Read More: Venture Capital Investment – 12 January 2011
By mobstr, on January 10th, 2012
Highlights from recent IT venture capital investment activity
North America
05.01.2012 – Emeryville, CA
Lithium Technologies Raises $53.4 Million in Financing
Lithium Technologies, the leader in Social Customer Experience, today announced that it has completed a $53.4 million round of financing, led by prominent new investor New Enterprise Associates and including new investor SAP Ventures as well as all . . . → Read More: IT Venture Capital Investment News Round Up – 10 January 2012
By mobstr, on January 9th, 2012
Highlights from recent Life Science venture capital news.
Secondary Venture Round
North America
04.01.2012 – Ann Arbor, MI
CytoPherx Raises $34 Million to Move Into U.S. Clinical Trials
CytoPherx (Fka Nephrion), today announced it has completed a $34 million round of funding. A large syndicate of investors co-led by Early Stage Partners, ONSET Ventures and Capital Midwest Fund, participated in the . . . → Read More: Life Science Venture Capital Investment News Round Up – 9 January 2012
By mobstr, on January 9th, 2012
Highlights from recent Life Science venture capital news.
28.12.2011 – Tustin, CA
Uptake Medical Raises $35M for Europe Launch
As it prepares to launch commercially in Europe, Uptake Medical Corp., a developer of medical technologies for interventional emphysema therapy, has raised $35.1 million of a funding round that will likely grow as large as $41.6 million, a person connected . . . → Read More: Life Science Venture Capital Investment News Round Up – 3 January 2012
|
|
Comments are closed 